v3.24.3
Consolidated Statements of Cash Flows
9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Cash Flows from Operating Activities    
Net loss $ (24,487,149) $ (41,168,866)
Adjustments to reconcile net loss to net cash used in operating activities:    
Goodwill impairment loss   3,873,079
Intangible asset impairment loss   2,277,921
Depreciation and amortization 5,371,248 4,668,589
Amortization of intangible asset   1,091,250
Noncash lease expense 270,778 318,073
Stock-based compensation 788,025 2,070,837
Change in fair value of contingent consideration   (177,354)
Change in fair value of contingent earn-out receivable, related party (1,190,000)  
Change in fair value of related party receivable (140,000)  
Change in fair value of non-convertible promissory note, related party 20,000  
Change in fair value of convertible promissory note, related party 224,250  
Payment of contingent consideration   (100,344)
Unrealized loss on investments (999) (99,437)
Loss on debt extinguishment 560,000  
Deferred tax liability   (571,120)
Accounts receivable (828,588) (7,022,657)
Other assets   (193,124)
Prepaid expenses and other current assets (379,592) 2,330,808
Inventory 734,102  
Grant receivable   1,524,522
Income tax receivable   600,877
Right-of-use assets   57,103
Deposits (26,622) 25,596
Accounts payable (1,695,391) (749,600)
Deferred revenue (48,577) 2,470,838
Accrued expenses and other liabilities 110,767 (1,681,915)
Net Cash Used In Operating Activities (20,717,748) (30,454,924)
Cash Flows from Investing Activities    
Purchase of short-term investments (933,193) (439,779)
Sale of intellectual property license 1,000,000  
Sale of short-term investments 2,890,355 32,208,771
Purchases of property and equipment (695,700) (1,852,665)
Disposal of property and equipment 564,692 220,802
Net Cash Provided by Investing Activities 2,826,154 30,137,129
Cash Flows from Financing Activities    
Proceeds from issuance of convertible promissory note, related party 2,253,750  
Proceeds from issuance of non-convertible promissory note, related party 750,000  
Proceeds from issuance of common stock 22,001,799  
Proceeds from issuance of common stock through at-the-market 8,399  
Proceeds from issuance of common stock upon exercise of warrants 178,424  
Proceeds from issuance of common stock under ESPP 12,904  
Stock issuance costs (2,219,868)  
Repayments of principal under finance lease (714,669) (2,751,037)
Net Cash Provided by (Used In) Financing Activities 22,270,739 (2,751,037)
Effect of exchange rate changes on cash and cash equivalents (4,736) (3,188)
Net Increase (Decrease) in Cash and Cash Equivalents 4,374,409 (3,072,020)
Cash and Cash Equivalents - Beginning of the Period 184,925 8,434,554
Cash and Cash Equivalents - End of the Period 4,559,334 5,362,534
Supplemental Disclosure for Cash Flow Information:    
Right-of-use assets obtained upon financing lease commencements   9,983,504
Right-of-use assets surrendered upon financing lease modifications   (3,092,408)
Right-of-use assets surrendered upon operating lease modifications (85,226)  
Right-of-use assets obtained upon operating lease modifications   87,839
Supplemental disclosure of non-cash investing and financing activities:    
Reclassification of contingent earn-out receivable, related party to related party receivable $ 1,430,000  
Reconciliation of cash and cash equivalents at September 30, 2024 and 2023    
Cash and cash equivalents included in current assets of discontinued operations   $ 3,319,793

Source